Kevin Southern MBChB, MRCP, FRCPCH, Ph.D.
Professor Southern joined the University of Liverpool and Alder Hey Children's Hospital on the 1st January 2000 and is Director of the Cheshire, Merseyside and North Wales Network of Paediatric Cystic Fibrosis Care with responsibility for the care of over 300 children with CF in the North West of England. He is the Chief Investigator for the national UK CF START study, a trial funded by the UK government to evaluate the safest and most effective antibiotic treatment strategy for infants with CF. In 2007, he helped establish the national UK Newborn Screening Programme for CF and he now chairs the national Board overseeing this programme. He was Leader of the European CF Society Neonatal Screening Working Group for more than ten years, handing over to Professor JÃ¼rg Barben in 2019. He is an Editor for the international Cochrane Review Group evaluating evidence for therapies for people with CF. In addition to his editorial role, he has written and contributed to 12 systematic reviews and his research is focused on translating evidence into practice. He has published over 100 peer reviewed articles on cystic fibrosis and is internationally respected for his work on newborn screening. He is the joint editor of a textbook sponsored by the European CF Society, the 'Early CF Years'. He is an elected member and Treasurer of the ECFS Board and, as such, has a global perspective on the issues facing people with CF.